Tafalgie Therapeutics
Operator of a biopharmaceutical research company intended to develop neuropathic and inflammatory pain drugs. The company specializes in the development of next-generation pain-relieving peptides with...
Valuation
$0
Share Price
N/A
Total Raised
$32M
Last Round
N/A